Patents by Inventor Thomas Steinbach

Thomas Steinbach has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6350472
    Abstract: A method for treating human immuno-deficiency virus infection (HIV-1), comprising administering a therapeutically effective amount of a mammalian liver extract characterized by being heat stable, insoluble in acetone, and soluble in water. A transdermal colloidal dispersion delivery system for use in the treatment of HIV-1 infection further comprises an emulsion of resolubilized, concentrated mammalian liver extract.
    Type: Grant
    Filed: December 14, 1998
    Date of Patent: February 26, 2002
    Assignee: Steinbach, Pylant, and Hermann, L.L.C.
    Inventors: Thomas Steinbach, Phillip R. Pylant, William J. Hermann, Jr.
  • Patent number: 6156349
    Abstract: A method for treating human immuno-deficiency virus infection (HIV-1), comprising administering a therapeutically effective amount of a mammalian liver extract characterized by being heat stable, insoluble in acetone, and soluble in water. A rectal suppository colloidal dispersion delivery system for use in the treatment of HIV-1 infection further comprises an emulsion of resolubilized, concentrated mammalian liver extract.
    Type: Grant
    Filed: December 14, 1998
    Date of Patent: December 5, 2000
    Assignee: Steinbach, Pylant and Herman, L.L.C.
    Inventors: Thomas Steinbach, Phillip R. Pylant, William J. Hermann, Jr.
  • Patent number: 5334395
    Abstract: A therapeutic method for treating Epstein-Barr virus infection. The method comprises administering a therapeutically-effective amount of a mammalian liver extract, the extract being characterized by being heat stable, insoluble in acetone and soluble in water, peptide or peptide fragment selected from the groups consisting of Sequence Identification Numbers 1-9.
    Type: Grant
    Filed: August 24, 1992
    Date of Patent: August 2, 1994
    Assignee: Kremers-Urban Company
    Inventors: Sudhakar S. Wagle, Thomas Steinbach, Carl H. Lawyer, William J. Hermann, Jr., Ali A. S. Gawish
  • Patent number: 5316775
    Abstract: A therapeutic method for treating hepatitis B infection. The method comprises administering a therapeutically-effective amount of a mammalian liver extract, the extract being characterized by being heat stable, insoluble in acetone and soluble in water, peptide or peptide fragment selected from the groups consisting of Sequence Identification Numbers 1-9.
    Type: Grant
    Filed: April 19, 1993
    Date of Patent: May 31, 1994
    Assignee: Kremers-Urban Company
    Inventors: Sudhakar S. Wagle, Thomas Steinbach, Carl H. Lawyer, William J. Hermann, Jr., Ali A. S. Gawish
  • Patent number: 5284664
    Abstract: A therapeutic method for treating Alzheimer's or related disease. The method comprises administering a therapeutically-effective amount of a mammalian liver extract, the extract being characterized by being heat stable, insoluble in acetone and soluble in water, peptide or peptide fragment selected from the groups consisting of Sequence Identification Numbers 1-9.
    Type: Grant
    Filed: February 5, 1992
    Date of Patent: February 8, 1994
    Assignee: Kremers-Urban Company
    Inventors: Sudhakar S. Wagle, Thomas Steinbach, Carl H. Lawyer, William J. Hermann, Ali A. S. Gawish
  • Patent number: 5055296
    Abstract: A therapeutic method for treating viral infections and chronic fatigue syndrome. The method comprises administering a therapeutically-effective amount of a mammalian liver extract, the extract being characterized by being heat stable, insoluble in acetone and soluble in water.
    Type: Grant
    Filed: August 4, 1988
    Date of Patent: October 8, 1991
    Inventors: Sudhakar S. Wagle, S. Ken Tanaka, Thomas Steinbach, Carl H. Lawyer, William J. Hermann, Jr.